<rss version="2.0" 
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
>

<channel>
	<title>News on European Medicines Evaluation Agency %28EMEA%29 from BioPortfolio.com</title>
	<link>http://www.BioPortfolio.com</link>
	<description>Consolidated European Medicines Evaluation Agency %28EMEA%29 news from BioPortfolio.com</description>
	<pubDate>Tue, 09 Feb 2010 23:23:39 GMT</pubDate>
	<language>en</language>
<atom:link href="http://www.bioportfolio.co.uk/cgi-bin/rssnews.pl?q=European+Medicines+Evaluation+Agency+%28EMEA%29" rel="self" type="application/rss+xml" />

	
<item><title>Daiichi Sankyo files Japanese new drug application for Alzheimer's drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035111&amp;HITNO=0&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035111&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536119166%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035111&amp;HITNO=0&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035111&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536119166%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>TradingMarkets:</description></item>
<item><title>Applications to Review Voclosporin Filed with FDA, EMA</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036483&amp;HITNO=1&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036483&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536632269%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4036483&amp;HITNO=1&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4036483&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536632269%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Biotechnology Healthcare:</description></item>
<item><title>Kamada initiates enrollment in Phase II/III study of inhalable AAT drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035192&amp;HITNO=2&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035192&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536155250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035192&amp;HITNO=2&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035192&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536155250%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Avi obtains European orphan drug designation for genetic disorder drug</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034957&amp;HITNO=3&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034957&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536067818%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034957&amp;HITNO=3&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034957&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536067818%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Individual.com:</description></item>
<item><title>Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038207&amp;HITNO=4&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038207&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4038207&amp;HITNO=4&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4038207&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537533156%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Therapeutics Daily:</description></item>
<item><title>Extreme Weather in Washington D.C. has Postponed the FDA's Oncologic Drugs Advisory Committee Meeting Schedule</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037862&amp;HITNO=5&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037862&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537335541%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037862&amp;HITNO=5&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037862&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537335541%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037858&amp;HITNO=6&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037858&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537334781%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4037858&amp;HITNO=6&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4037858&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2537334781%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Pharma Live:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035938&amp;HITNO=7&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035938&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536429350%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4035938&amp;HITNO=7&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4035938&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2536429350%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Genetic Engineering News:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034804&amp;HITNO=8&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034804&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535983333%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034804&amp;HITNO=8&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034804&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535983333%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Freshnews.com:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments - Zibb.com</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034548&amp;HITNO=9&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034548&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535852251%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034548&amp;HITNO=9&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034548&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535852251%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Zibb:</description></item>
<item><title>Targeted Genetics receives milestone payments from Genzyme and Amsterdam Molecular Therapeutics</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034528&amp;HITNO=10&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034528&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535838221%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034528&amp;HITNO=10&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034528&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535838221%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>News-Medical.Net:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034406&amp;HITNO=11&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034406&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535773554%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034406&amp;HITNO=11&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034406&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535773554%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>PR inside:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034395&amp;HITNO=12&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034395&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535769079%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034395&amp;HITNO=12&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034395&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535769079%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Earthtimes.org:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034386&amp;HITNO=13&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034386&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535758090%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034386&amp;HITNO=13&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034386&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535758090%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Forbes.com:</description></item>
<item><title>Targeted Genetics Receives Milestone Payments</title><link>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034383&amp;HITNO=14&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034383&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535755118%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</link><guid>http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&amp;ID=4034383&amp;HITNO=14&amp;MSIZE=728&amp;LANGUAGE=en&amp;FILE=doc.NEWSFEED&amp;SAVEQUERY00=European%20Medicines%20Evaluation%20Agency%20(EMEA)&amp;SAVEPROP00=L%3den&amp;SAVEDB=news&amp;SAVEORGANISE_CODED=R:date&amp;R=4034383&amp;THISHREF=http://c.moreover.com/click/here.pl%3fz2535755118%26amp%3bz%3d950242273&amp;THEHOST=site+d.moreover.com</guid><description>Street Insider:</description></item>
</channel></rss>